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Today, the Public Library of Science publishes a collection of
essays, perspectives, and reviews about how genomics, with all its
associated tools and techniques, can provide insights into our
understanding of emerging infectious disease (http://ploscollections.
org/emerginginfectiousdisease/) [1–13]. This collection, focused on
human disease, is particularly timely as pandemic H1N1 2009
influenza (commonly referred to as swine flu) spreads around the
globe, and government officials, the public, journalists, bloggers, and
tweeters strive to find out more. People want to know if this flu poses
more of a threat than other seasonal flu strains, how fast it’s
spreading (and where), and what can be done to contain it. As this
collection illustrates, the increasing speed at which complete genome
sequences and other genome-scale data can be generated for
individual isolates and strains of a pathogen provides tremendous
opportunities to identify the molecular changes in these disease
agents that will enable us to track their spread and evolution through
time (e.g., [3,7,8]) and generate the vaccines and drugs necessary to
combat them (e.g., [5–7]). The collection also shines a spotlight on
specific pathogens, some familiar and widespread, such as the
influenza A virus (e.g., [9]); some ‘‘reemerging,’’ such as the
Mycobacterium tuberculosis complex that causes tuberculosis [10]; and
some identified only recently, as with the bacterium Helicobacter pylori
(which causes peptic ulcers and gastric cancer [11]).
There is no simple definition of an emerging disease, but it can
be loosely described as a disease that is novel in some way—for
example, one that displays a change in geographic location,
genetics, or function. Emerging infectious diseases are caused by a
wide range of organisms, but they are perhaps best typified by
zoonotic viral diseases that cross from animal to human hosts and
can have a devastating impact on human health, causing a high
disease burden and mortality [8]. These zoonotic diseases include
monkeypox, Hendra virus, Nipah virus, and severe acute
respiratory syndrome coronavirus (SARS-CoV), in addition to
influenza A and the lentiviruses that cause AIDS. The apparently
increased transmission of pathogens from animals to humans over
the recent decades has been attributed to the unintended
consequences of globalization as well as environmental factors
and changes in agricultural practices [8]. Generally, the burden of
these diseases is most strongly felt by those in developing countries.
Brindley et al. [12] point to the debilitating effects of the most
common human infectious agent in such areas—helminths
(parasitic worms)—and the role that genomics plays in advancing
our understanding of molecular and medical helminthology.
Compounding the problem of emerging infectious diseases in
developing countries is the reality that researchers in developing
countries have often been unable to participate fully in genomics
research, because of their technological isolation and limited
resources. As Harris et al. emphasize [13], ‘‘collaborations—
starting with capacity building in genomics research—need to be
fostered so that countries that are currently excluded from the
genomics revolution find an entry point for participation.’’
This collection is a collaborative effort that combines financial
support from Google.org (which has also sponsored research on
emerging infectious disease through its Predict and Prevent
initiative [14]) with PLoS’s editorial independence and rigor.
Gupta et al. [1] provide Google.org’s perspective and vision for
how systematic application of genomics, proteomics, and bioinfor-
matics to infectious diseases could predict and prevent the next
pandemic. To realize this vision, they urge the community to unite
under an ‘‘Infectious Disease Genomics Project,’’ analogous to the
Human Genome Project. This is, as the authors admit, a
potentially ‘‘grandiose’’ and difficult proposition. Some researchers
might justifiably argue that much is already being achieved—as
demonstrated by this collection—and that the vision is naı ¨ve.
However, as every article in the collection also points out,
tremendous challenges remain if the potential of genomics in this
field is to be realized.
One problem is that, despite the fact that sequencing is now the
method of choice for characterizing new disease agents, and new
substantially faster and cheaper sequencing methods are contin-
ually being produced, we still lack the range of computational tools
necessary to analyze these sequences in sufficient detail [4]. It is
possible to sequence the entire assemblage of viruses in a particular
tissue type or host species [3] and to obtain complete or nearly
complete genome sequences for large samples of bacteria [7]. Yet
we remain in the early, albeit essential, stages of pathogen
discovery (Box 1). These sequences can be interpreted fully only
when integrated with relevant environmental, epidemiological,
and clinical data (e.g., [3,4,8]). And, despite the increased
sequencing, really comprehensive genome data are still only
available for a few key pathogens, which further limits our
understanding. For example, a full quantitative understanding of
the processes that shape the epidemiology and evolution—the
phylodynamics—of RNA viruses is currently possible only for HIV
and influenza A virus [3].
In this collection, you will find not only the views of leading
researchers from several different disciplines, and a provocative
vision from a funding agency, but also the contributions of six
different PLoS journals (PLoS Biology, PLoS Medicine, PLoS
Computational Biology, PLoS Genetics, PLoS Neglected Tropical Diseases,
and PLoS Pathogens). The PLoS open-access model of publishing
makes possible such a large multidisciplinary cross-journal
collection, in which all articles are simultaneously available online
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Our aim is that this collection will add to other ‘‘open science’’
activities that have helped provide insights into infectious disease
more quickly than would have been thought feasible only a few
years ago. This accelerated availability of research findings is
exemplified by the recent response to the flu pandemic. Consider,
for example, data access. Traditionally, scientists have released
data after publishing a study. Fortunately, in part due to
experience from genome sequencing projects, prepublication flu
sequence data have been released in a relatively unrestricted
manner to the community [15]. This has in turn enabled
anyone—not just those who collected the data—to carry out
analyses while the epidemic is occurring (when in principle there is
still time to save lives) rather than being forced to provide a
Box 1. A Field Guide to Microbes?
When an American robin (Turdus migratorius) showed up in London a few years ago, birders were rapidly all atwitter and many
came flocking to town [22]. Why had this one bird created such a stir? For one main reason—it was out of place. This species is
normally found in North America and only very rarely shows up on the other side of the ‘‘pond.’’ Amazingly, this rapid, collective
response is not that unusual in the world of birding. When a bird is out of place, people notice quickly.
This story of the errant robin gets to the heart of the subject of this collection because being out of place in a metaphorical way
is what defines an emerging infectious disease. Sometimes we have never seen anything quite like the organism or the disease
before (e.g., SARS, Legionella). Or perhaps, as with many opportunistic pathogens, we have seen the organism before but it was
not previously known to cause disease. In other cases, such as with as pandemic H1N1 2009 or E. coli O157:H7, we have seen
the organism cause disease before but a new form is causing far more trouble. And of course organisms can be literally out of
place, by showing up in a location not expected (e.g., consider the anthrax letters [2]).
Historically, despite the metaphorical similarities with the robin case, the response to emerging infectious disease is almost
always much slower. Clearly, there are many reasons for these differences, which we believe are instructive to consider. At least
four factors are required for birders’ rapid responses to the arrival of a vagrant bird: (1) knowledge of the natural ‘‘fauna’’ in a
particular place, (2) recognition that a specific bird may be out of place, (3) positive identification of the possibly out-of-place
bird, and (4) examination of the ‘‘normal’’ place for relatives of the identified bird.
How are these requirements achieved? Mostly through the existence of high-quality field guides that allow one to place an
organism such as a bird into the context of what is known about its relatives. This placement in turn is possible because of two
key components of field guides. First, such guides contain information about the biological diversity of a group of organisms.
This usually includes features such as a taxonomically organized list of species with details for each species on biogeography
(distribution patterns across space and time, niche preferences, relative abundance), biological properties (e.g., behavior, size,
shape, etc.), and genetic variation within the species (e.g., presence of subspecies). Second, a good field guide provides
information on how to identify particular types (e.g., species) of those organisms. With such information, and with a network of
interested observers, an out-of-place bird can be detected with relative ease.
In much the same way, a field guide to microbes would be valuable in the study of emerging infectious diseases. The articles in
this collection describe what can be considered the beginnings of species-specific field guides for the microbial agents of
emerging diseases. If we want to truly gain the benefits that can come from good field guides it will be necessary to expand
current efforts to include more organisms, more systematic biogeographical sampling, and more epidemiological and clinical
data. But the current efforts are a great start.
Figure: The American Robin (Turdus migratorius). (Photo Credit: NASA).
doi:10.1371/journal.pbio.1000224.g001
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highlights both the importance of early data access and the
removal of restrictions in the use of data (e.g., in many past cases
data might be released but use of the data in presentations and
publications would be limited).
The value of open access to sequence data is helping to put
pressure both on private organizations to release their sequence
data [16,17] and on all agencies to release other information (e.g.,
metadata about strains) more rapidly. This pressure is not being
brought to bear only on flu data—in this collection Van Voorhis
et al. [5] call on pharmaceutical companies to deposit the
structural coordinates of drug targets from all globally important
infectious disease organisms in public databases.
Of course, data about any infectious disease are not very useful
unless placed in the scientific context of past studies (i.e.,
publications) specifically about the disease or about methods to
analyze such data. It is also important to have access to
information about other diseases and other organisms that might
impact its spread or evolution. Perhaps the most intriguing aspect
of open science in response to flu has been the move toward pre-
journal publication release of findings. Many flu researchers took
the available data, analyzed it, and posted results on blogs [18,19],
wikis [20], and other sites. Although some view this ‘‘non peer-
reviewed’’ release as unseemly, it is clear that it has helped
accelerate the science in the study of pandemic H1N1 2009 and
led to some important journal papers [17]. Indeed, such advances
helped provide one of the stimuli for PLoS’s most recent initiative,
PLoS Currents: Influenza, a Google ‘‘Knol,’’ for the rapid
communication of research results and ideas about flu vetted by
expert moderators [21].
This is not to say there are no possible risks or drawbacks from
more openness. For example, some governments may avoid
releasing data because of fears about discrimination (as was seen in
many aspects of the flu in Mexico). Others worry that complete
openness might foster the spread of misinformation. However, as
Fricke et al. argue in their article on the relationship between
genomics and biopreparedness [2], open source genomic resources
are actually of immense benefit to those in charge of our public
health and biosecurity.
It is clear that ‘‘for all stages of combating emerging infections,
from the early identification of the pathogen to the development
and design of vaccines, application of sophisticated genomics tools
is fundamental to success’’ [8]. It is equally clear that open science
and open access to publications and data will be key to that
success. Whatever one’s position has been on the various open
science initiatives, there is no doubt that the ‘‘esoteric’’ label on
some open science initiatives has largely been eliminated by the
emergence of H1N1 flu epidemic.
The faster, cheaper, and more openly we can distribute the
discoveries of science, the better for scientific progress and public
health. As this collection emphasizes, managing the threat of
novel, re-emerging, and longstanding infectious diseases is
challenging enough even without barriers to scientific research.
We encourage you to make the most of this collection by sharing,
rating, and annotating the articles using our online commenting
tools. Better yet, join the discussion by providing your own vision
to prevent the emergence and spread of the next rogue pathogen.
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